Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes – significance of pregnancy planning and prepregnancy HbA1c
The aim of the study was to compare pregnancy outcomes with glycemic control, total increase in insulin requirement, and body weight gain in the women with Type 1 Diabetes Mellitus (T1DM) using continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI).
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Monika Żurawska-Kliś, Marcin Kosiński, Andżelika Kuchnicka, Milena Rurka, Judyta Hałucha, Marzena Wójcik, Katarzyna Cypryk Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Pregnancy | Study | Women